WuXi PharmaTech Successfully Implement Pharmaview Powered By Matrixview's ABO Technology
Apr 14, 2005
April 14, 2005 - Shanghai, China - WuXi PharmaTech Co., Ltd., today announced the successful development and implementation of PharmaView solution. PharmaView is powered by MatrixView Limited 's leading Adaptive Binary Optimisation (ABO) technology and jointly developed in conjunction with WuXi PharmaTech.
"PharmaView allows us to centralise and disseminate highly confidential and proprietary data to our clients in a secure yet 24x7 available environment, adding a new dimension to our services," said Dr Ge Li, Chairman and CEO of WuXi PharmaTech. "The compressed data by ABO technology enables our files to be 2 - 5 times smaller than our current pdf format, resulting in cost and time savings for our clients which are crucial in the pharmaceutical industry."The successful implementation of PharmaView could pave the way for the pharmaceutical and biotechnology industries to adopt ABO powered solutions as the underlying technology for the management and retrieval of highly confidential data and information.
"We have some of the biggest names in the pharmaceutical industry waiting eagerly to try out PharmaView as the ease of data management coupled by enhanced encryption features meant that the solution can be utilised within their organisation worldwide as well,"added Dr Ge Li.
PharmaView will be enhanced in the next version by a collaborative platform which allows participants with any internet connection to view and work on the same document simultaneously, with additional security and encryption features afforded by ABO technology.
"We are glad to have WuXi PharmaTech help us jointly define and develop this solution. With Dr. Ge Li's inputs and domain expertise, we believe we have created a truly compelling and innovative solution that the pharmaceutical industry urgently requires. This will truly become the de-facto platform for the pharmaceutical and biotechnology industries to adopt across their organisations, opening up tremendous licensing opportunities for MatrixView and its partners. This is yet another example of how ABO can revolutionise different industries and create never before possible solutions," said Mr. Ravi Govindan, chairman and managing director of MatrixView Ltd.
About MatrixView Limited: http://www.matrixview.com/ MatrixView is a leading core technology company specializing in providing data compression and optimization solutions. The company is developing its patent-pending Adaptive Binary Optimization (ABO(C)) technology for mission-critical industries such as medical, financial services, security, entertainment and defence by addressing unmet technology needs in these industries.
MatrixView's ABO-enabled technology solutions represent a paradigm shift in digital content management and will change the way in which data is managed, retrieved, stored and transmitted by removing the technical complexities and challenges of existing IT infrastructure and continuously breaking digital technology barriers.
About WuXi PharmaTech (Cayman) Inc. WuXi PharmaTech is a leading pharmaceutical, biotechnology and medical device R&D outsourcing company, with operations in China and the United States. As a research-driven and customer-focused company, WuXi PharmaTech provides pharmaceutical, biotechnology and medical device companies a broad and integrated portfolio of laboratory and manufacturing services throughout the drug and medical device R&D process. WuXi PharmaTech's services are designed to assist its global partners in shortening the cycle and lowering the cost of drug and medical device R&D. The operating subsidiaries of WuXi PharmaTech are known as WuXi AppTec. For more information, please visit: www.wuxiapptec.com.